IRONWOOD PHARMACEUTICALS INC Business Finance Contracts & Agreements
28 Contracts & Agreements
- Credit Agreements (5 contracts)
- Indenture Agreements (5)
- Investor Rights Agreements (1)
- Note Agreements (5)
- Purchase Agreements (1)
- Security Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (5)
- Indenture, dated as of August 12, 2019, by and between Ironwood Pharmaceuticals, Inc. and U.S. Bank National Association (including the form of the 1.50% Convertible Senior Note... (Filed With SEC on August 13, 2019)
- Indenture, dated as of August 12, 2019, by and between Ironwood Pharmaceuticals, Inc. and U.S. Bank National Association (including the form of the 0.75% Convertible Senior Note... (Filed With SEC on August 13, 2019)
- Call Spread Unwind Agreement, dated as of August 7, 2019, between Ironwood Pharmaceuticals, Inc. and Credit Suisse Capital LLC (Filed With SEC on August 13, 2019)
- Additional Call Option Transaction Confirmation for the 2026 Notes, dated as of August 12, 2019, between Ironwood Pharmaceuticals, Inc. and Credit Suisse Capital LLC (Filed With SEC on August 13, 2019)
- Additional Call Option Transaction Confirmation for the 2024 Notes, dated as of August 12, 2019, between Ironwood Pharmaceuticals, Inc. and Credit Suisse Capital LLC (Filed With SEC on August 13, 2019)
- Additional Call Option Transaction Confirmation for the 2026 Notes, dated as of August 12, 2019, between Ironwood Pharmaceuticals, Inc. and JPMorgan Chase Bank, National... (Filed With SEC on August 13, 2019)
- Additional Call Option Transaction Confirmation for the 2024 Notes, dated as of August 12, 2019, between Ironwood Pharmaceuticals, Inc. and JPMorgan Chase Bank, National... (Filed With SEC on August 13, 2019)
- Base Call Option Transaction Confirmation, for the 2026 Notes, dated as of August 7, 2019, between Ironwood Pharmaceuticals, Inc. and Credit Suisse Capital LLC (Filed With SEC on August 13, 2019)
- Base Call Option Transaction Confirmation for the 2024 Notes, dated as of August 7, 2019, between Ironwood Pharmaceuticals, Inc. and Credit Suisse Capital LLC (Filed With SEC on August 13, 2019)
- Base Call Option Transaction Confirmation for the 2026 Notes, dated as of August 7, 2019, between Ironwood Pharmaceuticals, Inc. and JPMorgan Chase Bank, National Association (Filed With SEC on August 13, 2019)
- Base Call Option Transaction Confirmation for the 2024 Notes, dated as of August 7, 2019, between Ironwood Pharmaceuticals, Inc. and JPMorgan Chase Bank, National Association (Filed With SEC on August 13, 2019)
- Purchase Agreement, dated as of August 7, 2019, between Ironwood Pharmaceuticals, Inc. and J.P. Morgan Securities LLC (Filed With SEC on August 13, 2019)
- Supplemental Indenture dated as of April 5, 2019 by and between Ironwood Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee (Filed With SEC on April 8, 2019)
- IRONWOOD PHARMACEUTICALS, INC. 2.25% CONVERTIBLE SENIOR NOTES DUE 2022 INDENTURE DATED AS OF JUNE 15, 2015 U.S. BANK NATIONAL ASSOCIATION, AS TRUSTEE (Filed With SEC on June 15, 2015)
- IRONWOOD PHARMACEUTICALS, INC. 2.25% Convertible Senior Notes due 2022 Purchase Agreement (Filed With SEC on June 15, 2015)
- RESTRICTED STOCK AGREEMENT IRONWOOD PHARMACEUTICALS, INC. (Filed With SEC on February 18, 2015)
- IRONWOOD PHARMACEUTICALS, INC. 13,725,500 Shares of Class A common stock Underwriting Agreement (Filed With SEC on February 12, 2014)
- RESTRICTED STOCK AGREEMENT IRONWOOD PHARMACEUTICALS, INC. (Filed With SEC on February 7, 2014)
- IRONWOOD PHARMACEUTICALS, INC. 10,500,000 Shares of Class A common stock Underwriting Agreement (Filed With SEC on May 24, 2013)
- IRONWOOD PHARMACEUTICALS, INC. AMENDED AND RESTATED 2010 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on February 21, 2013)
- INDENTURE dated as of January 4, 2013 by and between IRONWOOD PHARMACEUTICALS, INC., a Delaware corporation, as issuer of the Notes described herein, and U.S. BANK NATIONAL... (Filed With SEC on January 8, 2013)
- IRONWOOD PHARMACEUTICALS, INC. 5,250,000 Shares of Class A common stock Underwriting Agreement (Filed With SEC on February 15, 2012)
- IRONWOOD PHARMACEUTICALS,INC. Shares of Series ACommon Stock Underwriting Agreement (Filed With SEC on January 29, 2010)
- IRONWOOD PHARMACEUTICALS, INC. 2010 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 20, 2010)
- IRONWOOD PHARMACEUTICALS,INC. Shares of Series ACommon Stock Underwriting Agreement (Filed With SEC on January 20, 2010)
- MASTER SECURITY AGREEMENT No. 8081150 Dated as of January 16, 2009 (Agreement) (Filed With SEC on December 23, 2009)
- MICROBIA,INC. 1998AMENDED AND RESTATED STOCK OPTION PLAN Adoptedby Board of Directors on July 10, 1998 Amendedby Board of Directors on December 21, 1999 Approvedas Amended By... (Filed With SEC on December 23, 2009)
- EIGHTHAMENDED AND RESTATED INVESTORSRIGHTS AGREEMENT BY ANDAMONG IRONWOODPHARMACEUTICALS, INC., THEFOUNDERS AND THEINVESTORS NAMED IN EXHIBIT A September 1,2009 (Filed With SEC on November 20, 2009)
